2022年度研究發表

作者(順位) 論文題目 發表期刊
李健逢(4) Uncovering the Inhibitory Molecular Mechanism of Pomegranate Peel to Urinary Bladder Urothelial Carcinoma Using Proteomics Techniques. Life (Basel). 2022 Nov 9;12(11):1839. doi: 10.3390/life12111839.
吳麗卿(9), 李健逢(11), 賴弘岳(C) High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT. Pathol Res Pract. 2022 Nov;239:154158
李健逢(11) Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. Onco Targets Ther. 2022 Oct 11;15:1171-1181.
李宛珊(8), 李健逢(C) High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma. Oncology. 2022;100(9):485-497.
賴弘岳(2), 李宛珊(8), 李健逢(C) Upregulation of Cartilage Oligomeric Matrix Protein Predicts Poor Prognosis in Urothelial Carcinoma. Onco Targets Ther. 2022 Jun 30;15:727-740.
李健逢(C) Open the Technical Black Box of Tumor Mutational Burden (TMB): Factors Affecting Harmonization and Standardization of Panel-Based TMB. Int J Mol Sci. 2022 May 3;23(9):5097.
李健逢(2) Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1. Cancers (Basel). 2022 Mar 31;14(7):1787.
賴弘岳(1), 吳麗卿(5), 李健逢(C) High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis. Front Oncol. 2022 Mar 16;12:834249.
李健逢(C) Editorial: Molecular Mechanisms of Multiple Myeloma. Front Oncol. 2022 Mar 10;12:870123.
李健逢(C) Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression. Cells. 2022 Feb 11;11(4):638.
李健逢(10) Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements. Mod Pathol. 2022 Jul;35(7):911-921
李健逢(3) Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers. Clin Transl Med. 2022 Jan;12(1):e724.
賴弘岳(1), 吳麗卿(2), 龔柏勳(3), 李健逢(C) High Level of Aristolochic Acid Detected With a Unique Genomic Landscape Predicts Early UTUC Onset After Renal Transplantation in Taiwan. Front Oncol. 2022 Jan 6;11:828314.
李健逢(10) Molecular Characterization of Dermatofibrosarcoma Protuberans: The Clinicopathologic Significance of Uncommon Fusion Gene Rearrangements and Their Diagnostic Importance in the Exclusively Subcutaneous and Circumscribed Lesions. Am J Surg Pathol. 2022 Jul 1;46(7):942-955.
李健逢(5) Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions. Pathol Res Pract. 2022 Jan;229:153700.
賴弘岳(3) Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma. Clin Med Insights Oncol. 2022 Jul 22;16:11795549221113244.
賴弘岳(3) Formin-Like 2 Is a Potential Biomarker of Poor Prognosis in Nasopharyngeal Carcinoma. Oncology. 2022;100(9):475-484.
龔柏勳(1), 吳麗卿(5),李健逢(9) Discrimination of Methicillin-resistant Staphylococcus aureus by MALDI-TOF Mass Spectrometry with Machine Learning Techniques in Patients with Staphylococcus aureus Bacteremia Pathogens. 2022 May 16;11(5):586.
廖乃鼎(1) 以3D列印嬰兒足後跟模型於醫檢人員採血OSCE應用成效探討 台灣擬真醫學教育期刊/2022/第八卷第一期/15